Porcine β-defensin 2 displays broad antimicrobial activity against pathogenic intestinal bacteria

Molecular Immunology

Volumn 45, Issue 2, 2008, Pages 386-394

  Veldhuizen, Edwin J A ^a   Rijnders, Mariëlla ^a   Claassen, Erwin A ^b   van Dijk, Albert ^a   Haagsman, Henk P ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Antimicrobial peptide; Innate immunity; Pig

Indexed keywords

BETA DEFENSIN 2; SODIUM CHLORIDE;

ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ERYSIPELOTHRIX RHUSIOPATHIAE; HEMOLYSIS; INNATE IMMUNITY; INTESTINE FLORA; IONIC STRENGTH; LISTERIA MONOCYTOGENES; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SWINE; TRANSMISSION ELECTRON MICROSCOPY;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; BETA-DEFENSINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMOLYSIS; HUMANS; INTESTINES; KINETICS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA; OSMOLAR CONCENTRATION; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SEQUENCE ALIGNMENT; SWINE;

BACTERIA (MICROORGANISMS); ERYSIPELOTHRIX RHUSIOPATHIAE; LISTERIA MONOCYTOGENES; MAMMALIA; SALMONELLA TYPHIMURIUM; SUIDAE; SUS;

EID: 34548290744     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.06.001     Document Type: Article

References (36)

1. Aono S., Li C., Zhang G., Kemppainen R.J., Gard J., Lu W., Hu X., Schwartz D.D., Morrison E.E., Dykstra C., and Shi J. Molecular and functional characterization of bovine beta-defensin-1. Vet. Immunol. Immunopathol. 113 (2006) 181-190
2. Bals R., Goldman M.J., and Wilson J.M. Mouse beta-defensin-1 is a salt-sensitive antimicrobial peptide present in epithelia of the lung and urogenital tract. Infect. Immun. 66 (1998) 1225-1232
3. Bals R., Wang X., Wu Z., Freeman T., Bafna V., Zasloff M., and Wilson J.M. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Invest. 102 (1998) 874-880
4. Bensch K.W., Raida M., Mägert H.J., Schulz-Knappe P., and Forssmann W.G. hBD-1: a novel beta-defensin from human plasma. FEBS Lett. 368 (1995) 331-335
5. Chen X., Niyonsaba F., Ushio H., Okuda D., Nagaoka I., Ikeda S., Okumura K., and Ogawa H. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J. Dermatol. Sci. 40 (2005) 123-132
6. Goldman M.J., Anderson G.M., Stolzenberg E.D., Kari U.P., Zasloff M., and Wilson J.M. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88 (1997) 553-560
7. Hoover D.M., Chertov O., and Lubkowski J. The structure of human beta-defensin-1: new insights into structural properties of beta-defensins. J. Biol. Chem. 276 (2001) 39021-39026
8. Hoover D.M., Wu Z., Tucker K., Lu W., and Lubkowski J. Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob. Agents Chemother. 47 (2003) 2804-2809
9. Ishitsuka Y., Pham D.S., Waring A.J., Lehrer R.I., and Lee K.Y. Insertion selectivity of antimicrobial peptide protegrin-1 into lipid monolayers: effect of head group electrostatics and tail group packing. Biochim. Biophys. Acta 1758 (2006) 1450-1460
10. Jenssen H., Hamill P., and Hancock R.E. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19 (2006) 491-511
11. Jia H.P., Starner T., Ackermann M., Kirby P., Tack B.F., and McCray Jr. P.B. Abundant human beta-defensin-1 expression in milk and mammary gland epithelium. J. Pediatr. 138 (2001) 109-112
12. Klüver E., Schulz-Maronde S., Scheid S., Meyer B., Forssmann W.G., and Adermann K. Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry 44 (2005) 9804-9816
13. Lee H.Y., Andalibi A., Webster P., Moon S.K., Teufert K., Kang S.H., Li J.D., Nagura M., Ganz T., and Lim D.J. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenza. BMC Infect. Dis. 4 (2004) 12
14. Lehrer R.I. Primate defensins. Nat. Rev. Microbiol. 2 (2004) 727-738
15. Mandal M., Jagannadham M.V., and Nagaraj R. Antibacterial activities and conformations of bovine beta-defensin BNBD-12 and analogs:structural and disulfide bridge requirements for activity. Peptides 23 (2002) 413-418
16. Matsuzaki K., Sugishita K., Fujii N., and Miyajima K. Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry 34 (1995) 3423-3429
17. Pazgier M., Hoover D.M., Yang D., Lu W., and Lubkowski J. Human beta-defensins. Cell. Mol. Life Sci. 63 (2006) 1294-1313
18. Pazgier M., Prahl A., Hoover D.M., and Lubkowski J. Studies of the biological properties of human beta-defensin 1. J. Biol. Chem. 282 (2007) 1819-1829
19. Porter E.M., van Dam E., Valore E.V., and Ganz T. Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect. Immun. 65 (1997) 2396-2401
20. Sahl H.G., Pag U., Bonness S., Wagner S., Antcheva N., and Tossi A. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol. 77 (2005) 466-475
21. Sang Y., Ortega M.T., Blecha F., Prakash O., and Melgarejo T. Molecular cloning and characterization of three beta-defensins from canine testes. Infect. Immun. 73 (2005) 2611-2620
22. Sang Y., Patil A.A., Zhang G., Ross C.R., and Blecha F. Bioinformatic and expression analysis of novel porcine beta-defensins. Mamm. Genome 17 (2006) 332-339
23. Selsted M.E., and Ouellette A.J. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6 (2005) 551-557
24. Shi J., Zhang G., Wu H., Ross C., Blecha F., and Ganz T. Porcine epithelial beta-defensin 1 is expressed in the dorsal tongue at antimicrobial concentrations. Infect. Immun. 67 (1999) 3121-3127
25. Shimoda M., Ohki K., Shimamoto Y., and Kohashi O. Morphology of defensin-treated Staphylococcus aureus. Infect. Immun. 63 (1995) 2886-2891
26. Thouzeau C., Le Maho Y., Froget G., Sabatier L., Le Bohec C., Hoffmann J.A., and Bulet P. Spheniscins, avian beta-defensins in preserved stomach contents of the king penguin, Aptenodytes patagonicus. J. Biol. Chem. 278 (2003) 51053-51058
27. Tomita T., Hitomi S., Nagase T., Matsui H., Matsuse T., Kimura S., and Ouchi Y. Effect of ions on antibacterial activity of human beta defensin 2. Microbiol. Immunol. 44 (2000) 749-754
28. Valore E.V., Park C.H., Quayle A.J., Wiles K.R., McCray Jr. P.B., and Ganz T. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. 101 (1998) 1633-1642
29. van Dijk A., Veldhuizen E.J., Kalkhove S.I., Tjeerdsma-van Bokhoven J.L., Romijn R.A., and Haagsman H.P. The β-defensin gallinacin-6 is expressed in the chicken digestive tract and has antimicrobial activity against food-borne pathogens. Antimicrob. Agents Chemother. 51 (2007) 912-922
30. Veldhuizen E.J.A., Hendriks H.G., Hogenkamp A., van Dijk A., Gaastra W., Tooten P.C., and Haagsman H.P. Differential regulation of porcine beta-defensins 1 and 2 upon Salmonella infection in the intestinal epithelial cell line IPI-2I. Vet. Immunol. Immunopathol. 114 (2006) 94-102
31. Veldhuizen E.J.A., van Dijk A., Tersteeg M.H., Kalkhove S.I., van der Meulen J., Niewold T.A., and Haagsman H.P. Expression of β-defensins pBD-1 and pBD-2 along the small intestinal tract of the pig: lack of upregulation in vivo upon Salmonella typhimurium infection. Mol. Immunol. 44 (2007) 276-283
32. Wehkamp J., Fellermann K., Herrlinger K.R., Bevins C.L., and Stange E.F. Mechanisms of disease: defensins in gastrointestinal diseases. Nat. Clin. Pract. Gastroenterol. Hepatol. 2 (2005) 406-415
33. Wehkamp J., Salzman N.H., Porter E., Nuding S., Weichenthal M., Petras R.E., Shen B., Schaeffeler E., Schwab M., Linzmeier R., Feathers R.W., Chu H., Lima Jr. H., Fellermann K., Ganz T., Stange E.F., and Bevins C.L. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 18129-18134
34. Wu Z., Hoover D.M., Yang D., Boulègue C., Santamaria F., Oppenheim J.J., Lubkowski J., and Lu W. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 8880-8885
35. Zilbauer M., Dorrell N., Boughan P.K., Harris A., Wren B.W., Klein N.J., and Bajaj-Elliott M. Intestinal innate immunity to Campylobacter jejuni results in induction of bactericidal human beta-defensins 2 and 3. Infect. Immun. 73 (2005) 7281-7289
36. Zucht H.D., Grabowsky J., Schrader M., Liepke C., Jürgens M., Schulz-Knappe P., and Forssmann W.G. Human beta-defensin-1: a urinary peptide present in variant molecular forms and its putative functional implication. Eur. J. Med. Res. 3 (1998) 315-323